Jubilant Life Gets US Regulator Nod for Anti-Infection Drug

Drug firm Jubilant Life Sciences has received approval from the US health regulator to market generic levofloxacin tablets, used to treat various infections including pneumonia. The company has received approval from the US Food and Drug Administration (USFDA) to market generic version of Levaquin tablets in strengths of 250 mg and 500 mg in the American market, the firm said in a statement. The drug is used to treat adults with in...